| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/27/2000 | EP1037989A2 Nucleotide and protein sequence of mammastatin and methods of use |
| 09/27/2000 | EP1037987A2 14-3-3$g(s) ARRESTS THE CELL CYCLE |
| 09/27/2000 | EP1037986A1 Gene associated with neoplastic disease or malignancy associated gene |
| 09/27/2000 | EP1037985A1 Restin and methods of use thereof |
| 09/27/2000 | EP1037984A1 Cadherin-like polypeptides, methods and compositions related thereto |
| 09/27/2000 | EP1037983A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof |
| 09/27/2000 | EP1037981A1 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 09/27/2000 | EP1037980A1 G-protein coupled receptors associated with immune response |
| 09/27/2000 | EP1037974A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds |
| 09/27/2000 | EP1037970A1 Secreted proteins and polynucleotides encoding them |
| 09/27/2000 | EP1037969A1 Fibrinogen-converting enzyme hybrids |
| 09/27/2000 | EP1037967A2 Human phosphatases |
| 09/27/2000 | EP1037963A1 CRYSTAL COMPRISING HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE GLYCOPROTEIN gp120, COMPOUNDS INHIBITING CD4-gp120 INTERACTION, COMPOUNDS INHIBITING CHEMOKINE RECEPTOR-gp120 INTERACTION, MIMICS OF CD4 AND gp120 VARIANTS |
| 09/27/2000 | EP1037927A2 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 09/27/2000 | EP1037926A1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 09/27/2000 | EP1037925A2 Antagonists of neuropilin receptor functional and use thereof |
| 09/27/2000 | EP1037924A1 A transcriptional coactivator that interacts with tat protein and regulates its binding to tar rna |
| 09/27/2000 | EP1037923A1 Method for preparing by filtration a virally secure factor viii solution |
| 09/27/2000 | EP1037922A1 A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof |
| 09/27/2000 | EP1037921A1 Erythropoietin with high specific activity |
| 09/27/2000 | EP1037920A1 Molecules associated with the human suppressor of fused gene |
| 09/27/2000 | EP1037919A1 Proteins for cancer cell specific induction of apoptosis and method for isolation thereof |
| 09/27/2000 | EP1037915A1 Matrix-remodeling genes |
| 09/27/2000 | EP1037913A1 Galanin receptor galr3 and nucleotides encoding same |
| 09/27/2000 | EP1037912A1 DNA MOLECULES ENCODING VERTEBRATE NUCLEAR RECEPTOR PROTEIN, nNR4 |
| 09/27/2000 | EP1037911A1 Anti-pathogen system and methods of use thereof |
| 09/27/2000 | EP1037910A2 Maintenance of smooth muscle integrity by morphogenic proteins |
| 09/27/2000 | EP1037909A2 Postweaning multisystemic wasting syndrome virus from pigs |
| 09/27/2000 | EP1037908A2 Human tumor necrosis factor-r2-like proteins |
| 09/27/2000 | EP1037907A2 Bone morphogenetic protein (bmp) -17 and bmp-18 and compositions thereof |
| 09/27/2000 | EP1037906A1 Cyclopeptide derivatives with integrin inhibitor properties |
| 09/27/2000 | EP1037905A1 Antipicornaviral compounds and methods for their use and preparation |
| 09/27/2000 | EP1037901A1 Mammaglobin, a secreted mammary-specific breast cancer protein |
| 09/27/2000 | EP1037899A1 Secreted proteins and polynucleotides encoding them |
| 09/27/2000 | EP1037898A1 Secreted proteins |
| 09/27/2000 | EP1037665A1 Methods and compositions for inhibiting tumor cell growth |
| 09/27/2000 | EP1037663A2 Methods to treat undesirable immune responses |
| 09/27/2000 | EP1037661A1 ribH |
| 09/27/2000 | EP1037660A1 ribB |
| 09/27/2000 | EP1037659A1 Fibrinolytic inhibitor for sealant |
| 09/27/2000 | EP1037658A1 Ifnar2/ifn complex |
| 09/27/2000 | EP1037657A1 Alpha-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same |
| 09/27/2000 | EP1037656A1 Lymphotactin as an adjuvant |
| 09/27/2000 | EP1037655A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 09/27/2000 | EP1037654A1 ribA |
| 09/27/2000 | EP1037653A1 Compositions and methods for regulating phagocytosis and icam-1 expression |
| 09/27/2000 | EP1037652A1 Pharmaceutical compositions based on dalforpristin and quinupristin and preparation |
| 09/27/2000 | EP1037651A1 Small peptides and methods for treatment of asthma and inflammation |
| 09/27/2000 | EP1037650A1 Methods and compositions for the treatment and prevention of staphylococcus aureus infections |
| 09/27/2000 | EP1037649A1 Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| 09/27/2000 | EP1037648A2 The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases |
| 09/27/2000 | EP1037643A1 Cancer immunotherapy using allostimulated cells in a multiple sequential implantation strategy |
| 09/27/2000 | EP1037641A1 Transcription factor decoy and tumor growth inhibitor |
| 09/27/2000 | EP1037587A1 Site-specific preparation of polyethylene glycol-grf conjugates |
| 09/27/2000 | EP1037530A1 ribG |
| 09/27/2000 | EP1037529A1 Composition useful for providing one-step surgical preparation and drape |
| 09/27/2000 | EP0918792B1 Dipeptide benzamidine as a kininogenase inhibitor |
| 09/27/2000 | EP0831889A4 Use of il-13 to induce 15-lipoxygenase |
| 09/27/2000 | EP0777488A4 Composition and method for allogeneic mononuclear cell immunotherapy |
| 09/27/2000 | EP0764170B1 Branched synthetic peptide conjugate |
| 09/27/2000 | EP0689592B1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 09/27/2000 | EP0688224B1 A mutant crp-protein and methods and materials for making and using it |
| 09/27/2000 | EP0612216B1 Phospholipid antimicrobial compositions |
| 09/27/2000 | EP0575484B1 Composition comprising pdgf and dexamethasone for promoting tissue repair and regeneration |
| 09/27/2000 | CN1268176A Improved anti-IgE antibodies and method of improving polypeptides |
| 09/27/2000 | CN1268175A Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 09/27/2000 | CN1268174A Catalytic monoclonal antibodies for the vivo transformation of corticosteroid prodrugs |
| 09/27/2000 | CN1268061A Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 09/27/2000 | CN1268058A The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases |
| 09/27/2000 | CN1268053A Combination therapy comprising atorvastatin and an antihypertensive agent |
| 09/27/2000 | CN1267548A Sleep regulating composition prepared with melatonin and diazepam |
| 09/27/2000 | CN1267519A Immune regulator, immune regulator food and immune regulator fodder |
| 09/27/2000 | CN1056878C Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
| 09/27/2000 | CN1056851C Cyclic adhesion inhibitors |
| 09/26/2000 | US6124453 Sanglifehrins, immunosuppressant and antiinflammatory compounds |
| 09/26/2000 | US6124449 High affinity TGFβ nucleic acid ligands and inhibitors |
| 09/26/2000 | US6124448 Nucleic acid primers and probes for the mammalian OB gene |
| 09/26/2000 | US6124446 Polynucleotide sequence coding a vacuolar separation polypeptide; for the diagnosis, treatment, and prevention of cancer, inflammatory, lysosomal storage and membrane transport defects; anticarciongenic agents |
| 09/26/2000 | US6124439 OB polypeptide antibodies and method of making |
| 09/26/2000 | US6124438 Receptor protein which preferentially binds to neuronal tissues; for detection of injury to animal neuronal tissues |
| 09/26/2000 | US6124434 Human protein capable of adjustments in yeast; for the diagnosis, treatment and detection of cancer and cell proliferation defects; antitumor agents; anticarcinogenic agents |
| 09/26/2000 | US6124433 Polypeptide for use in the detection and monitoring of atherosclerosis, ischemia, hypertension, restenosis, and arterial inflammation |
| 09/26/2000 | US6124431 Peptide derivatives |
| 09/26/2000 | US6124328 Methods and compositions for stimulating neurite growth |
| 09/26/2000 | US6124315 Method for potentiating primary drugs in treating multidrug resistant disease |
| 09/26/2000 | US6124277 Antithrombotic agents |
| 09/26/2000 | US6124273 Sustained release wound healing agents |
| 09/26/2000 | US6124272 Antisense modulation of PDK-1 expression |
| 09/26/2000 | US6124270 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug |
| 09/26/2000 | US6124268 Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof |
| 09/26/2000 | US6124265 Method of making and cross-linking keratin-based films and sheets |
| 09/26/2000 | US6124264 Growth hormone secretagogue in a human or other animal to treat osteoporosis, congestive heart failure, aging, obesity; bone and wound healing agents |
| 09/26/2000 | US6124263 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 09/26/2000 | US6124262 Compositions and methods for reducing adhesiveness of defective red blood cells |
| 09/26/2000 | US6124261 Non-aqueous polar aprotic peptide formulations |
| 09/26/2000 | US6124260 Inhibition of smooth muscle cell migration by Tenascin-C peptides |
| 09/26/2000 | US6124259 Method for treating ophthalmic disorders with IGFBP |
| 09/26/2000 | US6124258 Heat resistant, sterilized carbonic acid-iron-casein complex lacking astringent taste; antianemia agents |
| 09/26/2000 | US6124257 Pulmonary delivery of a protease inhibitor together with a bioactive polypeptide to control presence of elastase |
| 09/26/2000 | US6124256 Administering an agonist specific for somatostatin (sst) receptor(s) showing an increased expression in the vascular wall subsequent to injury or surgery |